Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8+ T Cell Responses

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.02968
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA


Related search